VEGFA and renal cell carcinoma: EMMPRIN has been reported to stimulate tumor angiogenesis via vascular endothelial cell growth factor (VEGF) [22,23], but the correlation of EMMPRIN with the degree of angiogenesis has not been reported, and the roles of EMMPRIN in RCC are unclear.